Industry News

  1. Pfizer Strengthens Obesity Foothold With Metsera Acquisition 9/22/2025

    After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.

  2. FDA Cracks Down On GLP-1 Imports 9/11/2025

    GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.

  3. Oregon Court Upholds Drug Price Transparency Law 9/9/2025

    The law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.

  4. Spray Drying Market Poised To Nearly Double By 2033 9/2/2025

    The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.

  5. AbbVie Enters Psychedelic Market With Bretisilocin Acquisition 8/28/2025

    Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit

  6. J&J Commits $2 Billion To N.C. Manufacturing Facility 8/21/2025

    J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.

  7. FDA Launches PreCheck Program 8/12/2025

    The program introduces a two-phase approach to enable new U.S. drug manufacturing facilities: The Facility Readiness Phase and the Application Submission Phase.

  8. President Trump Demands MFN Prices In Manufacturer Letters 8/7/2025

    President Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.

  9. Bristol Myers Squibb Forms Immunology Company With Finance Partner 8/5/2025

    The NewCo pipeline will start with three clinical-stage and two phase 1-ready investigational medicines that each target mechanisms in autoimmune diseases.

  10. George Tidmarsh Named CDER Director 7/24/2025

    Tidmarsh has over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents.